In conclusion, modification of LNPswith the CD44-specific AKPClipopeptide greatly enhanced the in vivo tumor targetabilityof LNPs to breast cancer cells that had metastasized to the tail andwere located in situ in the hindbrain. This evidence concerns the gene CD44 and neoplasm.